Skip to main content

Advertisement

Log in

The mechanism of LSM2 in the progression of live hepatocellular carcinoma was analyzed based on bioinformatics

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Comprehensive analysis of the expression and probable function of LSM2 in Live hepatocellular carcinoma (LIHC), and validation via in vitro experiments. Integrated use of database resources to examine the differential expression, survival prognosis, clinicopathological characteristics, and functional enrichment of LSM2 in LIHC. The expression level of LSM2 in LIHC tissues and adjacent tissues was proven via immunohistochemical staining. The biological function of LSM2 in LIHC was detected by cell proliferation, cell cloning, cell scratch, cell migration, and invasion experiments in vitro. TIMER 2.0 and GEPIA indicated that LSM2 was highly expressed in cancers and was strongly associated with survival rates in LIHC, cholangiocarcinoma, breast cancer, and renal clear cell carcinoma. LSM2 was highly expressed in LIHC, which was closely associated to the clinicopathological characteristics of patients, and the overall survival rate and disease-free survival rate of patients with high expression of LSM2 were lower than those with low expression of LSM2. Functional enrichment results revealed that LSM2 was involved to ribosome formation, DNA replication, cell cycle, metabolic processes, JAK-STAT signaling pathways, and FoxO signaling pathways. Knockdown of LSM2 inhibited the proliferation, migration, and invasion of LIHC cells in vitro experiments. LSM2 was highly expressed in LIHC and was related to a poor prognosis. Knockdown of LSM2 could inhibit the proliferation, migration, and invasion of LIHC cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data availability

The datasets generated during and analysed during the current study are available from the corresponding author on reasonable request.

References

  1. Dasgupta P, Henshaw C, Youlden DR, et al. Global trends in incidence rates of primary adult liver cancers: A systematic review and meta-analysis. Front Oncol. 2020;10:171. https://doi.org/10.3389/fonc.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Lee GC, Ferrone CR, Vagefi PA, et al. Surgical resection versus ablation for early-stage hepatocellular carcinoma: A retrospective cohort analysis. Am J Sur. 2019;218(1):157–63. https://doi.org/10.1016/j.amjsurg.

    Article  Google Scholar 

  3. Wang H, Li W. Recent update on comprehensive therapy for advanced hepatocellular carcinoma. World J Gastrointest Oncol. 2021;13(8):845–55. https://doi.org/10.4251/wjgo.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Huang X, Liu S, Wu L, et al. High throughput single cell rna sequencing, bioinformatics analysis and applications. Adv Exp Med Biol. 2018;1068:33–43. https://doi.org/10.1007/978-981-13-0502-3_4.

    Article  CAS  PubMed  Google Scholar 

  5. Li C, Jiang W, Xu Y. Omics and bioinformatics: time for new data analysis approaches? OMICS. 2017;21(12):749. https://doi.org/10.1089/omi.2017.0120.

    Article  CAS  PubMed  Google Scholar 

  6. Saadoune C, Nouadi B, Hamdaoui H, et al. Multiple myeloma: bioinformatic analysis for identification of key genes and pathways. Bioinform Biol Insights. 2022;16:11779322221115544. https://doi.org/10.1177/11779322221115545.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Lekontseva NV, Stolboushkina EA, Nikulin AD. Diversity of LSM family proteins: Similarities and differences. Biochemistry (Mosc). 2021;86(Suppl 1):S38–49. https://doi.org/10.1134/S0006297921140042.

    Article  CAS  PubMed  Google Scholar 

  8. Bertram K, Agafonov DE, Dybkov O, et al. Cryo-EM structure of a pre-catalytic human spliceosome primed for activation. Cell. 2017;170(4):701-713e11. https://doi.org/10.1016/j.cell.2017.07.011.

    Article  CAS  PubMed  Google Scholar 

  9. Agafonov DE, Kastner B, Dybkov O, et al. Molecular architecture of the human U4/U6. U5 tri-snRNP. Science. 2016;351(6280):1416–20. https://doi.org/10.1126/science.aad2085.

    Article  CAS  PubMed  Google Scholar 

  10. Rahman N, Sun J, Li Z, et al. The cytoplasmic LSm1-7 and nuclear LSm2-8 complexes exert opposite effects on Hepatitis B virus biosynthesis and interferon responses. Front Immunol. 2022;13:970130. https://doi.org/10.3389/fimmu.2022.970130.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Liu J, Gu L, Zhang D, et al. Determining the prognostic value of spliceosome-related genes in hepatocellular carcinoma patients. Front Mol Biosci. 2022;9:759792. https://doi.org/10.3389/fmolb.2022.759792.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Zhuang H, Chen B, Tang C, et al. Identification of LSM family members as novel unfavorable biomarkers in hepatocellular carcinoma. Front Oncol. 2022;12:871771. https://doi.org/10.3389/fonc.2022.871771.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509–14. https://doi.org/10.1093/nar/gkaa407.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Li T, Fan J, Wang B, et al. TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108–10. https://doi.org/10.1158/0008-5472.CAN-17-0307.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Chandrashekar DS, Karthikeyan SK, Korla PK, et al. UALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18–27. https://doi.org/10.1016/j.neo.2022.01.001.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Li C, Tang Z, Zhang W, et al. GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA. Nucleic Acids Res. 2021;49(W1):W242–6. https://doi.org/10.1093/nar/gkab418.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Vasaikar SV, Straub P, Wang J, et al. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46(D1):D956–63. https://doi.org/10.1093/nar/gkx1090.

    Article  CAS  PubMed  Google Scholar 

  18. Perea-Resa C, Hernandez-Verdeja T, Lopez-Cobollo R, et al. LSM proteins provide accurate splicing and decay of selected transcripts to ensure normal Arabidopsis development. Plant Cell. 2012;24(12):4930–47. https://doi.org/10.1105/tpc.112.103697.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Spiller MP, Reijns MA, Beggs JD. Requirements for nuclear localization of the Lsm2-8p complex and competition between nuclear and cytoplasmic Lsm complexes. J Cell Sci. 2007;120(Pt 24):4310–20. https://doi.org/10.1242/jcs.019943.

    Article  CAS  PubMed  Google Scholar 

  20. Weichenrieder O. RNA binding by Hfq and ring-forming (L)Sm proteins: a trade-off between optimal sequence readout and RNA backbone conformation. RNA Biol. 2014;11(5):537–49. https://doi.org/10.4161/rna.29144.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Chen L, Roake CM, Freund A, et al. An activity switch in human telomerase based on RNA conformation and shaped by TCAB1. Cell. 2018;174(1):218-230e13. https://doi.org/10.1016/j.cell.2018.04.039.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Yang Y, Huang T, Fan Y, et al. Significance of spliceosome-related genes in the prediction of prognosis and treatment strategies for lung adenocarcinoma. Biomed Res Int. 2022;2022:1753563. https://doi.org/10.1155/2022/1753563.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Tang W, Kannan R, Blanchette M, et al. Telomerase RNA biogenesis involves sequential binding by Sm and Lsm complexes. Nature. 2012;484(7393):260–4. https://doi.org/10.1038/nature10924.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Collopy LC, Ware TL, Goncalves T, et al. LARP7 family proteins have conserved function in telomerase assembly. Nat Commun. 2018;9(1):557. https://doi.org/10.1038/s41467-017-02296-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Ta HDK, Wang WJ, Phan NN, et al. Potential therapeutic and prognostic values of LSM family genes in breast cancer. Cancers (Basel). 2021;13(19):4902. https://doi.org/10.3390/cancers13194902.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Sun X, Zhang J, Xiao C, et al. Expression profile and prognostic values of LSM family in skin cutaneous melanoma. BMC Med Genomics. 2022;15(1):238. https://doi.org/10.1186/s12920-022-01395-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Chen Z, Han C, Zhou X, et al. Prognostic value and potential molecular mechanism of the like-Sm gene family in early-stage pancreatic ductal adenocarcinoma. Transl Cancer Res. 2021;10(4):1744–60. https://doi.org/10.21037/tcr-20-3056.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Little EC, Camp ER, Wang C, et al. The CaSm (LSm1) oncogene promotes transformation, chemoresistance and metastasis of pancreatic cancer cells. Oncogenesis. 2016;5(1):e182. https://doi.org/10.1038/oncsis.2015.45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Chen L, Lin YH, Liu GQ, et al. Clinical significance and potential role of LSM4 overexpression in hepatocellular carcinoma: An integrated analysis based on multiple databases. Front Genet. 2021;12:804916. https://doi.org/10.3389/fgene.2021.804916.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This work was supported by the National Natural Science Foundation of China (NSFC, No. 82160517), The Guangxi Natural Science Foundation (2023GXNSFAA026081), Thousands of Young and Middle-aged Backbone Teachers in Guangxi Colleges and Universities Training Plan, and Guangxi Medical and Health Key Discipline construction project.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Haitao Huang, Jiahui Wang, Tingting Jiang, Nannan Zeng and Qi Wang. Yulin He and Yali Zhou directed the study and modified the article. The first draft of the manuscript was written by Peifang Qin and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Yulin He or Yali Zhou.

Ethics declarations

Conflict of interest

The authors have no relevant financial or non-financial interests to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qin, P., Huang, H., Wang, J. et al. The mechanism of LSM2 in the progression of live hepatocellular carcinoma was analyzed based on bioinformatics. Med Oncol 40, 276 (2023). https://doi.org/10.1007/s12032-023-02152-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-023-02152-0

Keywords

Navigation